Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Jackson Russo, Ph.D.
Assessor
US Food and Drug Administration
Poster(s):
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Tuesday, October 22, 2024
11:30 AM – 12:30 PM
MT
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Wednesday, October 23, 2024
11:30 AM – 12:30 PM
MT
